News|Videos|March 9, 2026

The Evolving Childhood Vaccine Schedule: Considerations for Those With Chronic Diseases, Immunocompromise

In this episode, the panel discusses the continued importance of getting all children vaccinated and the potential unintended consequences of fewer individuals being immunized if the current trends continue.

Although pediatric populations with developing chronic conditions or those who are at risk of being immunocompromised carry a potentially heavier burden for severe respiratory diseases such as respiratory syncytial virus (RSV) or influenza, Mary Koslap-Petraco, DNP, PNP-BC, CPNP, clinical assistant professor at Stony Brook University School of Nursing, pointed out the importance of all children obtaining the American Academy of Pediatrics’ recommended vaccines.

Related to this article

October 15th, 2026

VaxImpactMap Projects State-Level Burden of Declining Childhood Vaccination

Projected disease burden from declining childhood vaccine coverage shows increases in vaccine-preventable diseases. Benjamin Lopman, PhD, provides insights on how VaxImpactMap works and the potential long-term disease consequences of decreased immunization rates.

October 25th, 2026

Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants

Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.

October 21st, 2026

FDA Approves Bepirovirsen, First Antisense Therapy for Chronic Hepatitis B

The FDA approved bepirovirsen (Hibsago; GSK) with nucleos(t)ide analogue therapy for chronic hepatitis B, based on B-Well 1 and 2 functional cure rates of 19% vs 0% with placebo.

October 20th, 2026

Maternal Vaccination Shown to Protect Against K Pneumoniae Neonatal Sepsis

The first animal model of neonatal sepsis to evaluate protection by maternal vaccination evidences transfer of immunity against virulent, often antibiotic-resistant Klebseilla pneumoniae.

October 19th, 2026

CHMP Backs Extended Use of AstraZeneca H5N1 Pandemic Flu Vaccine

The CHMP adopted a positive opinion on an extension of indication for AstraZeneca's H5N1 pandemic influenza vaccine at its October meeting.

October 17th, 2026

FAQ: Ebola Prevention, Treatment and the Chances of a US Outbreak

As the Bundibugyo virus outbreak in the Democratic Republic of the Congo surpasses 9300 confirmed cases and 4400 deaths, this FAQ explains how the virus spreads, how it presents, why it is hard to diagnose and treat, which vaccines and therapies are being tested, and why CDC considers the risk to the United States low.

October 13th, 2026

Pennsylvania Coroner Reports Sixth Measles-Related Death

A 39-year-old unvaccinated Franklin County woman has died after a recent measles diagnosis. Nationally, numbers continue to increase and the US has passed 4,000 cases.

October 12th, 2026

NFID Survey Finds Respiratory Vaccine Gap Driven by Lack of Clarity, Not Hesitancy

The National Foundation for Infectious Diseases (NFID) recently held its respiratory season kick-off, which included the release of its annual respiratory disease survey. This year, the survey revealed the gap between vaccine support and uptake. Robert Hopkins Jr, MD, medical director of NFID delves deeper into the findings of the survey and the vaccine uptake challenges associated with certain immunizations.